LetterCorrespondence
Drs. Dai and Felson reply
Zhaoli Dai and David T. Felson
The Journal of Rheumatology February 2021, 48 (2) 303; DOI: https://doi.org/10.3899/jrheum.201222
Zhaoli Dai
1Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, and The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia;
2Boston University School of Medicine, Department of Medicine, Section of Rheumatology, Boston, Massachusetts, USA;
PhDRoles: Research Fellow
David T. Felson
2Boston University School of Medicine, Department of Medicine, Section of Rheumatology, Boston, Massachusetts, USA;
3Centre for Epidemiology, University of Manchester and the NIHR Manchester BRC, Manchester University NHS Trust, Manchester, UK.
MD, MPHRoles: Professor
REFERENCES
- 1.↵
- Yang CC,
- Hung PC.
- 2.↵
- Dai Z,
- Neogi T,
- Brown C,
- Nevitt M,
- Lewis CE,
- Torner J, et al.
- 3.↵
- 4.↵
- 5.↵
In this issue
The Journal of Rheumatology
Vol. 48, Issue 2
1 Feb 2021
Drs. Dai and Felson reply
Zhaoli Dai, David T. Felson
The Journal of Rheumatology Feb 2021, 48 (2) 303; DOI: 10.3899/jrheum.201222